Semi-Annual Statement Of Cash Flows

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7543334

Concept 2023-03-01 to
2023-08-31
As at
2023-08-31
As at
2023-02-28
As at
2022-08-31
2022-03-01 to
2022-08-31
As at
2022-02-28
Semi-annual statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
8,274,000,000 JPY
10,179,000,000 JPY
Interest and dividends received
1,499,000,000 JPY
870,000,000 JPY
Interest paid
-7,000,000 JPY
-4,000,000 JPY
Income taxes paid
-1,906,000,000 JPY
-2,881,000,000 JPY
Net cash provided by (used in) operating activities
7,851,000,000 JPY
8,162,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-4,686,000,000 JPY
-2,341,000,000 JPY
Purchase of investment securities
-8,000,000 JPY
-5,507,000,000 JPY
Proceeds from sale of investment securities
JPY
30,000,000 JPY
Other, net
1,000,000 JPY
346,000,000 JPY
Net cash provided by (used in) investing activities
10,443,000,000 JPY
-17,928,000,000 JPY
Cash flows from financing activities
Repayments of long-term borrowings
-33,000,000 JPY
-35,000,000 JPY
Purchase of treasury shares
-1,336,000,000 JPY
0 JPY
Dividends paid
-3,287,000,000 JPY
-3,357,000,000 JPY
Net cash provided by (used in) financing activities
-4,841,000,000 JPY
-3,641,000,000 JPY
Other, net
-73,000,000 JPY
-185,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
2,307,000,000 JPY
5,932,000,000 JPY
Net increase (decrease) in cash and cash equivalents
15,761,000,000 JPY
-7,475,000,000 JPY
Cash and cash equivalents
81,186,000,000 JPY
65,424,000,000 JPY
78,771,000,000 JPY
86,247,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.